Hanover Portfolio Acquisitions, Inc. announced that under the terms of the acquisition, Dr. Donnie Rudd, PhD, President of WeHealAnimals and a NASA recognized inventor for his work in stem cell research, has joined Hanover as its Chief Scientist and Director of Intellectual Property.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00105 USD | -4.55% |
|
+22.22% | -87.36% |
2023 | Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
2023 | Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval | CI |
1st Jan change | Capi. | |
---|---|---|
-87.36% | 417K | |
+20.03% | 126B | |
+23.61% | 117B | |
+22.68% | 27.52B | |
-18.07% | 20.87B | |
-14.08% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |
- Stock Market
- Equities
- ENDV Stock
- News Endonovo Therapeutics, Inc.
- Hanover Portfolio Acquisitions, Inc. Appoints Donnie Rudd as Director of Intellectual Property